Researchers isolate ß-carbolines from several species of Psilocybe.
A look into the less discussed therapeutic aspect of psychedelics: the anti-inflammatory effect.
This new knowledge provides more options for developing psychedelics into therapeutic drug formulations.
The center aims to quantify the chemicals in magic mushrooms and possibly identify new psychedelic molecules in them.
This is the first time psilocybin has been produced from a prokaryotic organism.
New research provides insight into the debate centered around the brain's capacity to synthesize DMT endogenously.
A 2014 study showed that psilocybin opens up communication between areas of the human brain that don't normally talk to each other.
The center is the first of its kind in the US and will propel psychedelic research to a new level.
With frequent appearances by Dr. Robin Carhart-Harris.
In spite of the hype, a new Imperial College study says the jury is still out.